pop up description layer

ISAP Researchers' Profiles

Steven Shoptaw, Ph.D.

Steven J.  Shoptaw is a licensed psychologist and Professor in the UCLA Departments of Family Medicine and Psychiatry and Biobehavioral Sciences.   Dr. Shoptaw joined the Department of Family Medicine as full professor in 2005. Prior to this, Dr. Shoptaw was a Research Psychologist with the Integrated Substance Abuse Program in the Dept. of Psychiatry & Behavioral Science since 2003.   Dr. Shoptaw earned his BA (1982) in Psychology and MA (1985) and Ph.D. (1990) in Psychology at UCLA.  His dissertation was nominated for the Gingerelli Award for Excellence in the Department of Psychology.  Dr. Shoptaw completed his postdoctoral training in Psychophysiology at the UCLA NPI/VAMC in Sepulveda, CA in 1991.  Following that, Dr. Shoptaw worked for 10 years as a Principal Investigator with Friends Research Institute, Inc., during which time, his program of clinical research with substance abusers supported opening several treatment research clinics in Rancho Cucamonga, Hollywood, South Los Angeles, and West Hollywood.  Dr. Shoptaw received the FRI Daniel Mendelsohn Young Investigator Award in 1996 and a mentoring award in 2000.  In 1996, Dr. Shoptaw opened Safe House, a 24 bed facility that provides emergency, transitional and permanent housing  to persons living with HIV/AIDS,  chemical dependency, transitional and permanent housing to persons living with HIV/AIDS, chemical dependency, and mental illness who are homeless or at risk for homelessness. He continues with this program as a volunteer Executive Director.  These linkages of clinical research  and community collaboration have led Dr. Shoptaw’s work to influence practice guidelines in intervening with substance abusers, especially those  at high risk for HIV transmission, locally, nationally and in emerging international epidemics.

Education and Training

  • University of California, Los Angeles, B.A., 1982, Psychology
  • University of California, Los Angeles, M.A., 1985, Psychology
  • University of California, Los Angeles, Ph.D., 1990, Clinical Psychology

Specialties

  • Medication Development for Methamphetamine Use

Contact Info

UCLA Department of Family Medicine
10880 Wilshire Blvd., Suite 1800
Los Angeles, CA 90095-7087
sshoptaw@mednet.ucla.edu
1.310.794.0619 ext. 233
1.310.794.2808 fax

Selected Publications

  1. Li J., Yang X., Wu Y., Shoptaw S., A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.  Statistics in Medicine.  (2007)  May 30;26(12):2519-32
  2. Shoptaw S., Reback C., Methamphetamine Use and Infectious Disease Related Behaviors In Men Who Have Sex With Men: Implications for Interventions.  ADDICTION 2007 (Suppl. 1) 130-135. 
  3. Menza TW., Colfax G, Shoptaw S., Fleming M., Guzman R., Klausner JD., Gorbach P., Golden MR., (2006)  Interest in a Methamphetamine Intervention Among Men Who Have Sex With Men. Journal of Sexually Transmitted Diseases  (2007) Apr; 34 (4):209-14.
  4. Heinzerling K., Shoptaw S., Peck J., Yang X., Liu J., Ling W., (2006) Randomized, Placebo-Controlled Trial of Baclofen and Gabapentin for the Treatment of Methamphetamine Dependence.  Drug and Alcohol Dependence   (2006)  Dec 1; 85(3):177-84.
  5. Strona F., McCright J., Hjord H., Ahrens K., Tierney S., Shoptaw S., Klausner J., The acceptability and feasibility of the Positive Reinforcement Opportunity Project, a community-based contingency management methamphetamine treatment program for gay and bisexual men in San Francisco.. Journal of Psychoactive Drugs 2006 Nov ;Suppl 3:377-83
  6. Shoptaw S., Reback C., Associations between Methamphetamine Use and HIV among Men Who Have Sex with Men: A Model for Guiding Public Policy.  Journal of Urban Health. 2006 Nov;83(6):1151-7
  7. Roll J. M., Huber, A., Sodano R., Chudzynski J. E., Moynier E., & Shoptaw S., (2006) A Comparison of Five Reinforcement Schedules for Use in Contingency Management-Based Treatment of Methamphetamine Abuse. Psychological Record. Vol. 56, 67-81.
  8. Larkins S., Reback C.J., Shoptaw S., (2006) HIV Risk Behaviors Among Gay Male Methamphetamine Users: Before and After Treatment.  Journal of Gay & Lesbian Psychotherapy Vol. 10 Issue 3/4.
  9. Shoptaw, S., Huber, A., Peck J.A., Yang, X., Liu, J., Roll, J., Shapiro, B., Rotheram-Fuller, E., Dang, J., Ling, W. (2006) Randomized, Placebo-Controlled Trial of Sertraline and Contingency Management for the Treatment of Methamphetamine Dependence. Drug and Alcohol Dependence  Vol. 85 Issue 1 Oct 15, 2006.
  10. Ling, W., Rawson R., Shoptaw S., (2006) Management of Methamphetamine Abuse and Dependence. Current Psychiatry Reports. October 345-54 (2006).
  11. Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, Gibson S, Siever M, King WD, Kao U, Dang J. A Public Health Response to The Methamphetamine Epidemic: The Implementation of Contingency Management to Treat Methamphetamine Dependence. BMC Public Health. Aug 18;6:214   (2006).        
  12. Gonzales R., Marinelli-Casey P., Shoptaw S., Ang A., Rawson R., Hepatitis C Virus infection among Methamphetamine-Dependent Individuals in Outpatient Treatment.  Journal of Substance Abuse Treatment 31 (2006) 195-202
  13. Shoptaw S., Methamphetamine use in urban gay and bisexual populations. Topics in HIV Medicine (2006) Jun-Jul 14(2):84-7.
  14. Roll J. M. & Shoptaw S., (2006) Contingency Management for the Treatment of Methamphetamine Abuse:  Schedule Effects.  Psychiatry Research.   Sep 30;144 (1):91-3.
  15. Yang, X., Shen Q., Xu, H., Shoptaw, S. Functional regression analysis using an F test for longitudinal data with large numbers of repeated measures. Statistics in Medicine, June 30,2006.
  16. Rawson R., McCann M., Flammino F., Shoptaw S., Miotto K., Reiber C., Ling W., (2005 ) A Comparison of Contingency Management and Cognitive-Behavioral Approaches for Stimulant-Dependent Individuals.  Addiction.  Feb;101(2):267-74
  17. Kanouse DE, Bluthenthal RN, Bogart L, Iguchi MY, Perry S, Sand K, Shoptaw S.(2005) Recruiting Drug-Using Men Who Have Sex with Men into Behavioral Interventions: A Two-Stage Approach. J Urban Health. Mar;82 (1 Suppl 1):i109-19.
  18. Nyamathi AM, Christiani A., Windoku F, Jones T, Strehlow A, Shoptaw S. (2005) Hepatitis C virus infection, substance  use and mental illness among homeless youth. Journal of Acquired Immune Deficiency Syndrome.  Oct; 19 Suppl 3:S34-40.
  19. Colfax G, Shoptaw S. (2005) The methamphetamine epidemic: implications for HIV prevention and treatment.  Current HIV/AIDS Rep. Nov; 2 (4):194-9.  Review. 
  20. Campos M, Shoptaw S., (2005) Evidence-Based Treatments for methamphetamine Abuse. Focus: A Guide to AIDS Research and Counseling, 20 (6) 5-8.
  21. Peck, J.A., Shoptaw, S., Rotheram-Fuller, E., Reback, C.J., Bierman, B. (2005). HIV-associated medical, behavioral, and psychiatric characteristics among methamphetamine-dependent treatment-seeking gay and bisexual men.  Journal of Addictive Diseases.  24: 115-132.
  22. Ling, W., Amass, L., Shoptaw, S., Annon, J.J., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muri, J., Buchan, B., Orr, D., Woody, G., Krejcija, J., Ziedonis, D., and the Burenorphine Study Protocol Group.  (2005) A multi-center randomized trial of buprenorphine-naloxone and clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network.  Addiction.  100:1090-1100.
  23. Larkins S, Reback CJ, Shoptaw S, Veniegas R. (2005). Methamphetamine-dependent gay men's disclosure of their HIV status to sexual partners.  AIDS Care. 17:521-532.
  24. Shoptaw, S., Reback, C.J., Peck, J.A., Yang, X., Rotheram-Fuller, E., Larkins, S., Veniegas, R.C., & Hucks-Ortiz, C. (2005). Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78(2) May 2005:125-134.
  25. Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid M, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, & Vocci F. (2005) Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence, Addiction, 100(Supplement 1): 91-101.
  26. Leiderman DB, Shoptaw S, Montgomery A, Bloch DA, Elkashef A, LoCastro J, & Vocci F. (2005) Cocaine rapid efficacy screening trial (CREST): A paradigm for the controlled evaluation of candidate medications for cocaine dependence, Addiction, 100(Supplement 1): 1-11.
  27. Kampman KM, Leiderman D, Holmes T, LoCastro J, Bloch DA, Reid MS, Shoptaw S, Montgomery MA, Winhusen TM, Somoza EC, Ciraulo DA, Elkashef A, & Vocci F. (2005). Cocaine rapid efficacy screening trials (CREST): Lessons learned, Addiction, 100(Supplement 1): 102-110.
  28. Peck JA, Reback CJ, Yang X, Rotheram-Fuller E, Shoptaw S. (2005). Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men.  J Urban Health, 82 (1Suppl 1):i100-i108.
  29. Shoptaw S, Watson DW, Reiber C, Rawson RA, Montgomery A, Majewska D, & Ling W. (2005). Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles cocaine rapid efficacy and safety trial (CREST), Addiction, 100(Supplement 1): 78-90.
  30. Shoptaw S. (2005). Clinical Rapid Efficacy Screening Trials (CREST; ed. S. Shoptaw). (2005). Addiction, 100(Supplement 1): 1-110.
  31. Yang, X., Shoptaw, S. (2005). Assessing Missing Data Assumptions in Longitudinal Studies: An Example Using a Smoking Cessation Trial. Drug and Alcohol Dependence, 77(3):213-225.

 

Last updated - 06/22/2007

Click here to view other profiles.

Top of Page
UCLA Home Page ISAP Home Page